Literature DB >> 11172910

Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome.

J Kameoka1, T Funato, Y Obara, I Kadowaki, H Yokoyama, T Kimura, Y Tomiya, M Yamada, I Ishikawa, M Takagawa, O Sasaki, J Kimura, H Harigae, I Miura, K Meguro, M Kaku, T Sasaki.   

Abstract

Tetrasomy 8, though rare, is usually associated with trisomy 8, a far more common chromosomal abnormality in acute myeloid leukemia (AML). Yet the clonal relationship between trisomy 8 and tetrasomy 8 in the cases with these chromosomal abnormalities has been unclear. Here, we report a case of a 17-year-old male, diagnosed as having a myelodysplastic syndrome (MDS). Chromosome analysis showed the presence of trisomy 8. Five years later, he developed overt AML exhibiting tetrasomy 8 only. After chemotherapy, the blast cells in the bone marrow decreased to 3.4%, and the karyotype showed trisomy 8 alone. Fluorescence in situ hybridization using a probe specific for chromosome 8 showed that the percentages of cells exhibiting 2/ 3 /4 signals were 7.8/89.2/2.0 at the MDS stage, 20.5/36.1/41.0 when overt AML developed and 24.0/72.1/2.4 after chemotherapy. These results suggested that tetrasomy 8 is derived from the AML clone, possibly evolved from the MDS clone with trisomy 8. To our knowledge, this is the first detailed case report of clonal evolution from trisomy 8 into tetrasomy 8 associated with the development of AML from MDS.

Entities:  

Mesh:

Year:  2001        PMID: 11172910     DOI: 10.1016/s0165-4608(00)00347-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Possibility of the diagnosis of subacute myeloid leukemia for a group of patients with trisomy 8: a report of 34 cases.

Authors:  Yan Zhang; Jing-Ying Qiu; Yue-Yun Lai; Dao-Pei Lu
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 2.  Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).

Authors:  Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R Sperr; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

3.  Trisomy 8 in leukemia: A GCRI experience.

Authors:  Sonal R Bakshi; Manisha M Brahmbhatt; Pina J Trivedi; Esha N Dalal; Dharmesh M Patel; Sejal S Purani; Shilin N Shukla; Pankaj M Shah; Prabhudas S Patel
Journal:  Indian J Hum Genet       Date:  2012-01

4.  Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.

Authors:  Sheryl M Gough; Yang Jo Chung; Peter D Aplan
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

5.  A case of acute myeloid leukemia (AML) with an unreported combination of chromosomal abnormalities: gain of isochromosome 5p, tetrasomy 8 and unbalanced translocation der(19)t(17;19)(q23;p13).

Authors:  Christian Paar; Gabriele Herber; Daniela Voskova; Michael Fridrik; Herbert Stekel; Jörg Berg
Journal:  Mol Cytogenet       Date:  2013-09-30       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.